Keller-Pintér A - Search Results

1

Self-Assembling Injectable Hydrogel for Controlled Drug Delivery of Antimuscular Atrophy Drug Tilorone.

Abdelghafour MM, Deák Á, Kiss T, Budai-Szűcs M, Katona G, Ambrus R, Lőrinczi B, Keller-Pintér A, Szatmári I, Szabó D, Rovó L, Janovák L. Abdelghafour MM, et al. Among authors: keller pinter a. Pharmaceutics. 2022 Dec 6;14(12):2723. doi: 10.3390/pharmaceutics14122723. Pharmaceutics. 2022. PMID: 36559217 Free PMC article.

2

Cell-penetrating peptide exploited syndecans.

Letoha T, Keller-Pintér A, Kusz E, Kolozsi C, Bozsó Z, Tóth G, Vizler C, Oláh Z, Szilák L. Letoha T, et al. Biochim Biophys Acta. 2010 Dec;1798(12):2258-65. doi: 10.1016/j.bbamem.2010.01.022. Epub 2010 Feb 2. Biochim Biophys Acta. 2010. PMID: 20138023 Free article.

3

Skeletal muscle cellularity and glycogen distribution in the hypermuscular Compact mice.

Kocsis T, Baán J, Müller G, Mendler L, Dux L, Keller-Pintér A. Kocsis T, et al. Eur J Histochem. 2014 Jul 28;58(3):2353. doi: 10.4081/ejh.2014.2353. Eur J Histochem. 2014. PMID: 25308840 Free PMC article.

4

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.

Keller-Pinter A, Ughy B, Domoki M, Pettko-Szandtner A, Letoha T, Tovari J, Timar J, Szilak L. Keller-Pinter A, et al. PLoS One. 2017 Nov 9;12(11):e0187094. doi: 10.1371/journal.pone.0187094. eCollection 2017. PLoS One. 2017. PMID: 29121646 Free PMC article.

5

Contribution of syndecans to lipoplex-mediated gene delivery.

Letoha T, Kolozsi C, Ekes C, Keller-pintér A, Kusz E, Szakonyi G, Duda E, Szilák L. Letoha T, et al. Eur J Pharm Sci. 2013 Jul 16;49(4):550-5. doi: 10.1016/j.ejps.2013.05.022. Epub 2013 Jun 1. Eur J Pharm Sci. 2013. PMID: 23732629

6

Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro.

Hajdú T, Kovács P, Zsigrai E, Takács R, Vágó J, Cho S, Sasi-Szabó L, Becsky D, Keller-Pinter A, Emri G, Rácz K, Reglodi D, Zákány R, Juhász T. Hajdú T, et al. Among authors: keller pinter a. Front Oncol. 2021 Sep 20;11:681603. doi: 10.3389/fonc.2021.681603. eCollection 2021. Front Oncol. 2021. PMID: 34616669 Free PMC article.

7

Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity.

Kocsis T, Trencsenyi G, Szabo K, Baan JA, Muller G, Mendler L, Garai I, Reinauer H, Deak F, Dux L, Keller-Pinter A. Kocsis T, et al. Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E150-E160. doi: 10.1152/ajpendo.00216.2016. Epub 2016 Dec 13. Am J Physiol Endocrinol Metab. 2017. PMID: 27965203 Free article.

8

The compact mutation of myostatin causes a glycolytic shift in the phenotype of fast skeletal muscles.

Baán JA, Kocsis T, Keller-Pintér A, Müller G, Zádor E, Dux L, Mendler L. Baán JA, et al. J Histochem Cytochem. 2013 Dec;61(12):889-900. doi: 10.1369/0022155413503661. Epub 2013 Aug 26. J Histochem Cytochem. 2013. PMID: 23979839 Free PMC article.

9

Syndecan-4 in Tumor Cell Motility.

Keller-Pinter A, Gyulai-Nagy S, Becsky D, Dux L, Rovo L. Keller-Pinter A, et al. Cancers (Basel). 2021 Jul 1;13(13):3322. doi: 10.3390/cancers13133322. Cancers (Basel). 2021. PMID: 34282767 Free PMC article. Review.

10

Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors.

Szabo K, Varga D, Vegh AG, Liu N, Xiao X, Xu L, Dux L, Erdelyi M, Rovo L, Keller-Pinter A. Szabo K, et al. Among authors: keller pinter a. Cell Mol Life Sci. 2022 Feb 7;79(2):122. doi: 10.1007/s00018-021-04121-0. Cell Mol Life Sci. 2022. PMID: 35128576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page